SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Hepatitis
An SI Board Since March 2001
Posts SubjectMarks Bans
312 28 0
Emcee:  tuck Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
37Stressgen presents data at vaccine conference on next CoVal(TM) fusion in pipelirusset-5/7/2003
36New drugs block hepatitis C Thursday April 17, 1:59 pm ET By Maggie Fox, Healthscaram(o)uche-4/17/2003
35A number of other similar findings: ncbi.nlm.nih.gov ncbi.nlm.nih.gov and I bkeokalani'nui-4/3/2003
34>>Published online before print April 3, 2003 Proc. Natl. Acad. Sci. USA, tuck-4/3/2003
33Progenics Pharmaceuticals Discovers the First Liver-Specific Receptor for Hepatikeokalani'nui-4/1/2003
32<i>synergistic antiviral effects of combination use of Infergen and interfnigel bates-3/31/2003
31Novartis / Idenix Message 18754539 <i>Upon closing of the transaction, Nonigel bates-3/26/2003
30Enanta / Chiron WATERTOWN, Mass.--(BUSINESS WIRE)--March 12, 2003--Enanta Pharmnigel bates-3/12/2003
29[siRNA versus HCV] >>Published online before print December 23, 2002, 10.tuck-1/13/2003
28Pathology >>Published online before print November 19, 2002 Proc. Natl. Atuck-11/22/2002
27A Jules Levin reporting from AASLD: natap.org Changing the number after the datuck-11/6/2002
26aasld abstract, off of embargo....... Publishing ID: 237 Abstractid ID: 102152 scaram(o)uche-11/6/2002
25WELLESLEY, Mass., and LANGENFELD, Germany, Oct. 30 /CNW/ -- Coley Pharmaceuticalrusset-10/30/2002
24>>WASHINGTON -- Roche Holding AG announced Wednesday it won U.S. governmentuck-10/17/2002
23J Biol Chem 2002 Aug 6; [epub ahead of print] Identification and biological chscaram(o)uche-8/10/2002
22As you probably know, Novirio has been trying to get out the window, when and ifscaram(o)uche-7/6/2002
21>>Antivir Chem Chemother 2001;12 Suppl 1:119-29 Antiviral beta-L-nucleostuck-7/6/2002
20>>J Hepatol 2002 Jul;37(1):109-16 High doses of interferon in combinatiotuck-7/6/2002
19Thanks Tuck. Need to do DD on the safety issue. "However, the LFTs returnMiljenko Zuanic-5/21/2002
18>>First Clinical Trial of IDN-6556: First Anti-Apoptotic Caspase Inhibitortuck-5/20/2002
17Anyone with more details (abstract)about this PI study?Miljenko Zuanic-5/20/2002
16Idun Pharmaceuticals Announces Results of Successful Phase 1 Clinical Trial - Fikeokalani'nui-5/20/2002
15From www.nytimes.com - May 14, 2002 More Are Finding Permanent Cures for Hepatmichael_f_murphy-5/14/2002
14If you compare the figures for worldwide carriers of HBV given towards the bottotuck-4/18/2002
13>>CHICAGO, April 18 /PRNewswire/ -- A combination treatment of Pegasys (petuck-4/18/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):